Market Place
Sourcing Support
All News #Library
Biotech
Whitehawk Therapeutics Showcases Next-Gen ADC Portfolio Data
20 Apr 2026 //
PR NEWSWIRE
Whitehawk Identifies MUC16 As Key Target for Gynecologic Cancers
10 Apr 2026 //
PR NEWSWIRE
Whitehawk Therapeutics Showcases Next-Gen ADC Portfolio At AACR
18 Mar 2026 //
PR NEWSWIRE
Whitehawk Presents at 36th Oppenheimer Healthcare Conference
18 Feb 2026 //
PR NEWSWIRE
Whitehawk Clears IND for HWK-007, Submits IND for HWK-016
08 Jan 2026 //
PR NEWSWIRE
Whitehawk Confirms PTK7 as Broadly Expressed Cancer Target
24 Oct 2025 //
PR NEWSWIRE
Tempus, Whitehawk Partner on Biomarker-Based Cancer Research
16 Oct 2025 //
BUSINESSWIRE
Whitehawk Therapeutics joins BTIG Virtual Biotech Conference
22 Jul 2025 //
PR NEWSWIRE
Whitehawk Completes Sale of Aadi Subsidiary to Kaken Pharma
26 Mar 2025 //
PR NEWSWIRE
Aadi Bioscience becomes Whitehawk Therapeutics, focusing on ADCs
18 Mar 2025 //
PR NEWSWIRE
Aadi buys preclinical ADCs, sells Fyarro to reboot business
20 Dec 2024 //
FIERCE BIOTECH
Aadi Bio In-Licenses ADC Portfolio, Sells FYARRO®, $100M Financing
19 Dec 2024 //
PR NEWSWIRE
Aadi to Present Multiple at the AACR Annual Meeting 2023
06 Apr 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.